Deficient Caveolin-1 Synthesis in Adipocytes Stimulates Systemic Insulin-Independent Glucose Uptake via Extracellular Vesicles
Open Access
- 26 July 2022
- journal article
- research article
- Published by American Diabetes Association in Diabetes
- Vol. 71 (12) , 2496-2512
Abstract
Caveolin-1 (cav1) is an important structural and signaling component of plasma membrane invaginations called caveolae and is abundant in adipocytes. As previously reported, adipocyte-specific ablation of the cav1 gene (ad-cav1 knockout [KO] mouse) does not result in elimination of the protein, as cav1 protein traffics to adipocytes from neighboring endothelial cells. However, this mouse is a functional KO because adipocyte caveolar structures are depleted. Compared with controls, ad-cav1KO mice on a high-fat diet (HFD) display improved whole-body glucose clearance despite complete loss of glucose-stimulated insulin secretion, blunted insulin-stimulated AKT activation in metabolic tissues, and partial lipodystrophy. The cause is increased insulin-independent glucose uptake by white adipose tissue (AT) and reduced hepatic gluconeogenesis. Furthermore, HFD-fed ad-cav1KO mice display significant AT inflammation, fibrosis, mitochondrial dysfunction, and dysregulated lipid metabolism. The glucose clearance phenotype of the ad-cav1KO mice is at least partially mediated by AT small extracellular vesicles (AT-sEVs). Injection of control mice with AT-sEVs from ad-cav1KO mice phenocopies ad-cav1KO characteristics. Interestingly, AT-sEVs from ad-cav1KO mice propagate the phenotype of the AT to the liver. These data indicate that ad-cav1 is essential for healthy adaptation of the AT to overnutrition and prevents aberrant propagation of negative phenotypes to other organs by EVs.Keywords
All Related Versions
Funding Information
- Diabetes Research & Wellness Foundation (2334)
- Novo Nordisk (NNF19OC0056601)
- Swedish Diabetes Foundation (DIA2019-419)
- Swedish Research Council (2013-07107, 2017-00792, 2020-01463)
- National Institutes of Health (1S10OD025002-01, F32-DK-122623, K99-DK122019, P01-AG051459, P51-OD01192, R00-DK122019, R01-108773, R01-DK099110, R01-DK127274, R01-DK131537, R01-DK55758, RC2-DK118620)
This publication has 31 references indexed in Scilit:
- Caveolin-1 Deficiency Leads to Increased Susceptibility to Cell Death and Fibrosis in White Adipose Tissue: Characterization of a Lipodystrophic ModelPLOS ONE, 2012
- Altered Mitochondrial Function and Metabolic Inflexibility Associated with Loss of Caveolin-1Cell Metabolism, 2012
- Study of caveolin-1 gene expression in whole adipose tissue and its subfractions and during differentiation of human adipocytesNutrition & Metabolism, 2010
- Increased basal level of Akt-dependent insulin signaling may be responsible for the development of insulin resistanceAmerican Journal of Physiology-Endocrinology and Metabolism, 2009
- Association of a Homozygous Nonsense Caveolin-1 Mutation with Berardinelli-Seip Congenital LipodystrophyThe Journal of Clinical Endocrinology & Metabolism, 2008
- Reexpression of caveolin-1 in endothelium rescues the vascular, cardiac, and pulmonary defects in global caveolin-1 knockout miceJournal of Experimental Medicine, 2007
- Expression of caveolin‐1 in human adipose tissue is upregulated in obesity and obesity‐associated type 2 diabetes mellitus and related to inflammationClinical Endocrinology, 2007
- Lipid droplets and lamellar bodies – from innocent bystanders to prime targets of lipid research for combating human diseasesEuropean Journal of Lipid Science and Technology, 2006
- Caveolin-1-deficient mice show insulin resistance and defective insulin receptor protein expression in adipose tissueAmerican Journal of Physiology-Cell Physiology, 2003
- Caveolin-1-deficient Mice Are Lean, Resistant to Diet-induced Obesity, and Show Hypertriglyceridemia with Adipocyte AbnormalitiesJournal of Biological Chemistry, 2002